CR20110590A - Formas estables de n-(2,6-dimetil-4-morfolin-4-il-fenil)3,3- dimetil-butiramida - Google Patents

Formas estables de n-(2,6-dimetil-4-morfolin-4-il-fenil)3,3- dimetil-butiramida

Info

Publication number: CR20110590A
Authority: CR; Costa Rica
Prior art keywords: dimetil; butiramida; morfolin; fenil; stable forms
Prior art date: 2009-05-11

Application number

CR20110590A

Other languages

English (en)

Spanish (es)

Inventor

Svend Treppendahl

Karin Liltorp

De Diego Heidi Lopez

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-05-11

Filing date

2011-11-11

Publication date

2012-02-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42237259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20110590(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-11-11 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2012-02-22 Publication of CR20110590A publication Critical patent/CR20110590A/es

Links

150000001875 compounds Chemical class 0.000 abstract 1
OVEJXWFUXCATFY-UHFFFAOYSA-N n-(2,6-dimethyl-4-morpholin-4-ylphenyl)-3,3-dimethylbutanamide Chemical compound CC1=C(NC(=O)CC(C)(C)C)C(C)=CC(N2CCOCC2)=C1 OVEJXWFUXCATFY-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Neurology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Cosmetics (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

CR20110590A 2009-05-11 2011-11-11 Formas estables de n-(2,6-dimetil-4-morfolin-4-il-fenil)3,3- dimetil-butiramida CR20110590A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA200900597		2009-05-11

Publications (1)

Publication Number	Publication Date
CR20110590A true CR20110590A (es)	2012-02-22

Family

ID=42237259

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CR20110590A CR20110590A (es)	2009-05-11	2011-11-11	Formas estables de n-(2,6-dimetil-4-morfolin-4-il-fenil)3,3- dimetil-butiramida

Country Status (23)

Country	Link
EP (1)	EP2430008A2 (fr)
JP (1)	JP2012526152A (fr)
KR (1)	KR20120022934A (fr)
CN (1)	CN102459208A (fr)
AR (1)	AR076556A1 (fr)
AU (1)	AU2010246724B2 (fr)
BR (1)	BRPI1013930A2 (fr)
CA (1)	CA2761383A1 (fr)
CL (1)	CL2011002814A1 (fr)
CO (1)	CO6460741A2 (fr)
CR (1)	CR20110590A (fr)
DO (1)	DOP2011000351A (fr)
EA (1)	EA201171381A1 (fr)
GE (1)	GEP20146006B (fr)
IL (1)	IL216148A0 (fr)
MA (1)	MA33351B1 (fr)
MX (1)	MX2011011885A (fr)
NZ (1)	NZ596738A (fr)
SG (1)	SG175968A1 (fr)
TN (1)	TN2011000557A1 (fr)
TW (1)	TW201041857A (fr)
WO (1)	WO2010130260A2 (fr)
ZA (1)	ZA201108112B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US12508239B2 (en)	2019-08-02	2025-12-30	H. Lundbeck A/S	Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or seizures

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI349666B (en) *	2004-03-12	2011-10-01	Lundbeck & Co As H	Substituted morpholine and thiomorpholine derivatives
NZ575652A (en) *	2006-08-23	2011-08-26	Valeant Pharmaceuticals Int	Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
CN101790374A (zh) *	2007-08-01	2010-07-28	H.隆德贝克有限公司	Kcnq钾通道开放剂用于减轻多巴胺能系统受到干扰的障碍或病症的症状或治疗这种障碍或病症的用途

2010
- 2010-05-06 TW TW099114459A patent/TW201041857A/zh unknown
- 2010-05-10 AR ARP100101588A patent/AR076556A1/es unknown
- 2010-05-11 JP JP2012510116A patent/JP2012526152A/ja active Pending
- 2010-05-11 CN CN2010800321765A patent/CN102459208A/zh active Pending
- 2010-05-11 AU AU2010246724A patent/AU2010246724B2/en not_active Ceased
- 2010-05-11 CA CA2761383A patent/CA2761383A1/fr not_active Abandoned
- 2010-05-11 NZ NZ596738A patent/NZ596738A/xx not_active IP Right Cessation
- 2010-05-11 MX MX2011011885A patent/MX2011011885A/es not_active Application Discontinuation
- 2010-05-11 GE GEAP201012498A patent/GEP20146006B/en unknown
- 2010-05-11 EP EP10719726A patent/EP2430008A2/fr not_active Withdrawn
- 2010-05-11 KR KR1020117026958A patent/KR20120022934A/ko not_active Withdrawn
- 2010-05-11 BR BRPI1013930A patent/BRPI1013930A2/pt not_active IP Right Cessation
- 2010-05-11 SG SG2011082492A patent/SG175968A1/en unknown
- 2010-05-11 EA EA201171381A patent/EA201171381A1/ru unknown
- 2010-05-11 WO PCT/DK2010/050101 patent/WO2010130260A2/fr not_active Ceased
- 2010-05-11 MA MA34435A patent/MA33351B1/fr unknown
2011
- 2011-11-03 IL IL216148A patent/IL216148A0/en unknown
- 2011-11-04 ZA ZA2011/08112A patent/ZA201108112B/en unknown
- 2011-11-04 TN TNP2011000557A patent/TN2011000557A1/en unknown
- 2011-11-10 CL CL2011002814A patent/CL2011002814A1/es unknown
- 2011-11-11 DO DO2011000351A patent/DOP2011000351A/es unknown
- 2011-11-11 CO CO11153611A patent/CO6460741A2/es not_active Application Discontinuation
- 2011-11-11 CR CR20110590A patent/CR20110590A/es unknown

Also Published As

Publication number	Publication date
AR076556A1 (es)	2011-06-22
AU2010246724B2 (en)	2013-03-21
GEP20146006B (en)	2014-01-10
WO2010130260A3 (fr)	2011-06-16
CA2761383A1 (fr)	2010-11-18
WO2010130260A9 (fr)	2012-10-18
DOP2011000351A (es)	2012-01-31
SG175968A1 (en)	2011-12-29
CN102459208A (zh)	2012-05-16
MX2011011885A (es)	2011-12-06
ZA201108112B (en)	2013-01-30
CL2011002814A1 (es)	2012-04-13
AU2010246724A1 (en)	2011-12-08
TW201041857A (en)	2010-12-01
WO2010130260A2 (fr)	2010-11-18
MA33351B1 (fr)	2012-06-01
NZ596738A (en)	2013-04-26
IL216148A0 (en)	2012-01-31
EP2430008A2 (fr)	2012-03-21
KR20120022934A (ko)	2012-03-12
EA201171381A1 (ru)	2012-05-30
BRPI1013930A2 (pt)	2019-09-24
JP2012526152A (ja)	2012-10-25
CO6460741A2 (es)	2012-06-15
TN2011000557A1 (en)	2013-05-24

Publication	Publication Date	Title
PT3320912T (pt)	2021-05-24	Imunoterapia à base de indoleamina 2,3-dioxigenase
BRPI0923325A2 (pt)	2016-01-12	métodos para usar um composto, e para suprimir a produção deum composto de isocianato livre.
CR10157A (es)	2008-10-29	Compuestos químicos
UY34515A (es)	2013-07-31	Triazolopiridinas sustituidas
UA113643C2 (xx)	2017-02-27	N-цикліламіди як нематоциди
UY34559A (es)	2013-07-31	Inhibidores de bromodominios
UY34765A (es)	2013-11-29	Compuestos novedosos.
CR20140448A (es)	2014-11-11	Metodo para unir partes de metal
UY34302A (es)	2013-04-05	COMPUESTOS DE HEXAHIDROPIRANO[3,4-d][1,3]TIAZIN-2- AMINA
AR061311A1 (es)	2008-08-20	Procesos para preparar clorhidrato de cinacalcet y formas polimorficas del mismo
BRPI1014691A2 (pt)	2015-08-25	Composto, e, processo para a preparação de um composto.
CL2012002082A1 (es)	2013-07-26	Proceso para la preparacion de lacosamida, por hidroximetilación; compuestos intermediarios.
EA201000258A1 (ru)	2010-08-30	Новые гербициды
UY34329A (es)	2013-04-30	Compuestos de triazolopiridina
CR20110208A (es)	2011-05-11	Proceso para la preparación de benzonorbornenos
ECSP11011190A (es)	2011-09-30	Anticuerpos monoclonales anti-rhd
ECSP13012914A (es)	2013-11-29	Síntesis de derivados de 2-carboxamida-cicloamino-urea
FR2973475B1 (fr)	2018-05-25	Module d'eclairage, a homogeneite d'eclairage amelioree.
UY34791A (es)	2013-11-29	N-etil-4-hidroxil-1-metil-5-(metil(2,3,4,5,6-pentahidroxihexil)amino)-2-oxo-n-fenil-1,2- dihidroquinolina-3-carboxamida
UY34072A (es)	2013-01-03	Derivados sustituidos de indol
BRPI0922064A2 (pt)	2015-12-15	processo para preparar uma amida secundaria.
AR058253A1 (es)	2008-01-30	Procedimiento para la preparacion de ferri-succinilcaseina
BRPI0814581A2 (pt)	2017-05-09	processo para a preparação de um composto, e, composto.
CR20120169A (es)	2012-07-30	Procesos para la preparación de 2-(1-feniletil)-isoindolin-1-ona
BRPI0819653A2 (pt)	2014-11-04	Método para a produção de um composto de tetrapirrol, e, composto de tetrapirrol.